Insights

May 18, 2021

Preventative Action Reduces Clotting Risk

The risk of blood clots is associated with many activities and health conditions, including smoking, long airline flights, birth control pills, diabetes, and cancer. It’s especially important to determine whether cancer patients have any additional conditions that further increase their likelihood of developing a blood clot. In this case study, when our cancer patient Bob developed symptoms consistent with a blood clot, we acted immediately. Read now

May 18, 2021

‘Long COVID’ is Real: Here’s What You Need to Know

Many COVID-19 patients are still battling symptoms long after the virus is no longer detected. While there is currently no consensus definition for this condition, patients suffering from "post-COVID-19 syndrome" can be separated into two cohorts: “post-acute COVID-19 syndrome” (PACS) and “Long COVID” (chronic COVID-19 syndrome; CCS)”. Read now

May 18, 2021

Monitoring the Latest COVID-19 Developments

Since the start of the pandemic, Private Health has been committed to keeping our clients informed of the latest COVID-19 developments, providing access to tests, diagnostics, and therapeutics. Here's our latest FAQ. Read now

April 21, 2021

COVID-19 Vaccines, Variants and Post-Vaccine Living

Our experts discuss available COVID-19 vaccines, variants of concern and what the world looks like post-pandemic. Watch now

April 19, 2021

Keeping a Close Watch on Cancer

A cancer diagnosis is scary. And when the cancer has spread to other places in the body, it is often considered incurable – even scarier. However, due to progress in cancer research over the last couple of decades, even cancers that have spread can go into remission or be managed more like a chronic disease. In these scenarios, it is incredibly important to use every tool in our cancer toolbox to monitor for disease progression or recurrence. Read now

April 19, 2021

Cell-free DNA for non-invasive cancer management and early detection

Precision treatment for cancer relies on understanding the nature of the tumor cells, including analyzing their DNA to identify alterations that help drive cancer cell growth. Often, the analysis is performed on tumor tissue from a biopsy or surgery. However, sometimes tissue is limited or unavailable. Emerging roles for cell-free DNA analysis can overcome these challenges and much more. Read now

March 24, 2021

Advocating with Urgency During Uncertain Times

This is the story of a client who came back from the brink of death in his battle with COVID-19. Forty-one-year-old Joseph had no history of health problems when he, his wife, Elaine, and their daughter came down with COVID-19 last December. While his wife and daughter recovered quickly, Joseph was not so lucky. Read now

March 24, 2021

Tracking the latest COVID-19 developments

COVID-19 is among the most researched diseases in history and has generated public interest and conversation about the underlying science. A high volume of COVID-19 data from clinical trials, scientific journals, and drug research are emerging at a very rapid pace. Read now

March 01, 2021

Utility of Serial Transcriptomic Analyses to Characterize the Resistome and to Refine Treatment Selection for Metastatic Colon Cancer

Private Health researchers and clinicians recently published a case study in the journal Clinical Colorectal Cancer, highlighting the importance of molecular profiling to identify precision, life-changing medicines to patients. Read now

February 26, 2021

A Personal Journey Through Cancer

Behind every cancer diagnosis is a person with individual needs, hopes and dreams - like Hannah, a vibrant mother of three who was in the prime of her life when she was diagnosed with cancer. In that moment, she was no longer just a mother, a successful professional, or a woman who loved horseback riding - she was a cancer patient. Read now

February 26, 2021

Unlocking the power of complementary and alternative medicine

Our clients with cancer count on Private Health to present them with all treatment options both traditional and non-traditional. We take a comprehensive view of cancer treatments including established anti-cancer drugs and investigational therapies, but also complementary and alternative medicine. Read now